1. Scrip
  2. >>Business

As COVID-19 Vaccine Sales Surge, BioNTech Pledges 40% Will Go To Poorer Nations

EU Adds Huge 1.8 Billion Dose Order

 
• By Andrew McConaghie

Angela Merkel consulted company’s CEO before opposing IP waiver, backing the future of Germany’s new ‘big biotech’ company.

BioNTech
BioNTech has a market cap of over $48bn, making it Europe's first true 'big biotech' company.

BioNTech will earn a minimum of €12.4bn ($15.08bn) in revenues from its COVID-19 vaccine Comirnaty co-developed with Pfizer this year, with that figure expected to keep growing in response to global demand.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip

The 2025 Scrip Awards Is Open For Entries

Entries for the Scrip Awards are now open. Now in their 21st year, the Awards seek to reward the outstanding achievements of the pharmaceutical, biotech and allied industries in improving human health.

US-China Tariff War Pressures Pharma’s Complex Supply Chain

 
• By Lisa Takagi

Although pharmaceuticals are exempt from the US reciprocal tariff policy, for now, the escalating global trade war is already posing practical on-the-ground problems for some companies, Scrip hears.

AstraZeneca Logs Japan Growth Despite Price Cuts

 
• By Lisa Takagi

AstraZeneca logs growth in Japan despite a big reimbursement price cut for one of its top sellers and expects 40 approvals in the country over the next six years.